recombinetics news
Recombinetics Announces Collaboration with Mayo Clinic to Develop the First-Ever Swine Models of Osteogenesis Imperfecta
Recombinetics today announced a collaborative research project with Mayo Clinic [...]
Company Statement & FAQs on Plasmid Insertion Found in First Gene-Edited Bull
Recombinetics, Inc. has recently been the focus of a series [...]
Recombinetics Awarded National Institutes of Health Funding to Develop Genetically Engineered Swine Model of Glioblastoma, the Deadliest Type of Brain Tumor
In honor of Glioblastoma Awareness Day (#GBMDay), Recombinetics today announced [...]
The Alliance to End Surgical Castration of Swine Announces Precision Breeding Successes
Multiple healthy litters of naturally castrated piglets developed through precision [...]
Acceligen and Kheiron-Biotech Announce Joint Projects Focused on Precision Breeding
Project Aims to Introduce New Commercial Traits in Cattle Derived [...]
Recombinetics Names Dr. Tad Sonstegard the First Chief Executive Officer of Its Wholly-Owned Subsidiary, Acceligen
Today, Recombinetics named Dr. Tad Sonstegard the first Chief Executive [...]
